Patent Reporting. Within sixty (60) days after each Calendar Year, CoLucid shall provide Lilly with a written report describing the status of all Licensed Patents, including the patent country, patent and application numbers, filing date, issue date, expiration date, and any other relevant information requested by Lilly. Such report shall be mailed to ▇▇▇ ▇▇▇▇▇ and Company, Lilly Royalty Administration in Finance, Drop Code ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇ (unless Lilly advises otherwise in writing) with a copy to the General Patent Counsel.
Appears in 2 contracts
Sources: Development and License Agreement (CoLucid Pharmaceuticals, Inc.), Development and License Agreement (CoLucid Pharmaceuticals, Inc.)